Disposition of 14C-LY2452473 Following Oral Administration in Healthy Human Subjects

NCT01275157 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: LY2452473

Sponsor

Eli Lilly and Company